GSK closing neuroscience R&D center in Shanghai

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it plans to close its Neuroscience R&D Center in Shanghai "following a portfolio review and prioritization."

Spokesperson Mary Anne Rhyne told BioCentury that GSK will move "key programs" to its global R&D hub in Upper Providence Township, Pa., where the pharma will "benefit from co-location with other pipeline R&D programs."...